PHARMACEUTICAL COMPOSITION FOR TREATING TRPV1 ACTIVITY-MEDIATED DISEASES

摘要

The present invention relates to a novel therapeutic pharmaceutical composition and, more particularly, to a pharmaceutical composition for treating TRPV1 activity-mediated diseases. Since the composition for the treatment of pain using inhibition of TRPV1 activity of the present invention exhibited an excellent effect of inhibiting neuropathic pain caused by spinal nerve damage, the composition can be used as a novel pain treatment for various pain conditions and diseases related to the TRPV1 channel, such as arthritis and diabetic peripheral neuropathy. In addition, since the composition effectively inhibits TRPV1 activity, the composition can be used as a therapeutic agent to treat various TRPV1 activity-mediated diseases.